MILLENNIUM MANAGEMENT LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$2,153,224
-82.6%
685,740
-71.4%
0.00%
-83.3%
Q2 2023$12,367,694
+226290.2%
2,396,840
+131.2%
0.01%
+100.0%
Q1 2023$5,463
+2417.5%
1,036,555
+1240.6%
0.00%
Q4 2022$217
-100.0%
77,322
-61.5%
0.00%
Q3 2022$834,000
-40.6%
201,074
-42.4%
0.00%
-100.0%
Q2 2022$1,404,000
-61.4%
349,201
-52.5%
0.00%
-50.0%
Q1 2022$3,642,000
+78.8%
735,733
+151.8%
0.00%
+100.0%
Q4 2021$2,037,000
-27.6%
292,192
+3.9%
0.00%
-50.0%
Q3 2021$2,813,000
+1208.4%
281,279
+1757.4%
0.00%
Q2 2021$215,000
-93.3%
15,144
-92.2%
0.00%
-100.0%
Q1 2021$3,188,000
+121.7%
194,295
+2.8%
0.00%0.0%
Q3 2020$1,438,000
+637.4%
189,007
+706.4%
0.00%
Q2 2020$195,000
-96.1%
23,437
-97.7%
0.00%
-100.0%
Q1 2020$5,030,000
+3345.2%
1,016,076
+2654.1%
0.01%
Q4 2019$146,000
-82.6%
36,893
-82.5%
0.00%
-100.0%
Q4 2018$837,000
-24.0%
210,273
+31.3%
0.00%0.0%
Q3 2018$1,102,000
+299.3%
160,155
+278.0%
0.00%
Q1 2018$276,000
+178.8%
42,369
+91.0%
0.00%
Q4 2017$99,000
+23.8%
22,177
+70.3%
0.00%
Q3 2017$80,000
-84.9%
13,021
-79.5%
0.00%
-100.0%
Q4 2016$530,000
+268.1%
63,370
+118.5%
0.00%
Q2 2016$144,000
-94.5%
28,997
-89.5%
0.00%
-100.0%
Q4 2015$2,595,000
+703.4%
276,978
+1184.7%
0.01%
+400.0%
Q3 2014$323,00021,5590.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders